{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:46:32Z","timestamp":1791049592948,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31471262"],"award-info":[{"award-number":["31471262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Major Project of China","award":["2012ZX10001-006"],"award-info":[{"award-number":["2012ZX10001-006"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.pharmthera.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T22:43:36Z","timestamp":1462056216000},"page":"120-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Diverse roles of HDAC6 in viral infection: Implications for antiviral therapy"],"prefix":"10.1016","volume":"164","author":[{"given":"Linlin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Aneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.04.005_bb0005","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1189\/jlb.0312165","article-title":"BET bromodomain inhibition as a novel strategy for reactivation of HIV-1","volume":"92","author":"Banerjee","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1257037","article-title":"Influenza a virus uses the aggresome processing machinery for host cell entry","volume":"346","author":"Banerjee","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00636-12","article-title":"Inhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by IRF-3 are regulated by the acetylation and phosphorylation of its coactivators","volume":"4","author":"Chattopadhyay","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.15252\/embj.201592586","article-title":"HDAC6 regulates cellular viral RNA sensing by deacetylation of RIG-I","volume":"35","author":"Choi","year":"2016","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0025","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1462-5822.2006.00745.x","article-title":"Systems biology of virus entry in mammalian cells","volume":"8","author":"Damm","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0030","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1038\/emboj.2011.283","article-title":"Coupling viruses to dynein and kinesin-1","volume":"30","author":"Dodding","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2005.09.024","article-title":"The interferon response circuit: Induction and suppression by pathogenic viruses","volume":"344","author":"Haller","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1091\/mbc.E09-01-0044","article-title":"Posttranslational modifications of tubulin and the polarized transport of kinesin-1 in neurons","volume":"21","author":"Hammond","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cytogfr.2007.06.002","article-title":"Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response","volume":"18","author":"Hiscott","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0055","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1074\/jbc.M110.208884","article-title":"Regulation of tat acetylation and transactivation activity by the microtubule-associated deacetylase HDAC6","volume":"286","author":"Huo","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0060","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1128\/JVI.00727-14","article-title":"Histone deacetylase 6 inhibits influenza a virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules","volume":"88","author":"Husain","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0065","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.febslet.2009.07.005","article-title":"Influenza a virus-induced caspase-3 cleaves the histone deacetylase 6 in infected epithelial cells","volume":"583","author":"Husain","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.febslet.2010.11.023","article-title":"Enhanced acetylation of alpha-tubulin in influenza a virus infected epithelial cells","volume":"585","author":"Husain","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tcb.2012.07.006","article-title":"Regulation from within: The cytoskeleton in transmembrane signaling","volume":"22","author":"Jaqaman","year":"2012","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1134\/S0006297914070050","article-title":"Selective inhibitor of histone deacetylase 6 (tubastatin a) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes","volume":"79","author":"Kozlov","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0090","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.bmcl.2015.04.016","article-title":"Pyridine hydroxamic acids are specific anti-HCV agents affecting HDAC6","volume":"25","author":"Kozlov","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0095","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI44932","article-title":"Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape","volume":"121","author":"Lazaro","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0854.2006.00408.x","article-title":"Viral strategies for intracellular trafficking: Motors and microtubules","volume":"7","author":"Leopold","year":"2006","journal-title":"Traffic"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0105","doi-asserted-by":"crossref","first-page":"10803","DOI":"10.1128\/JVI.00320-14","article-title":"The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events","volume":"88","author":"Lucera","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2008.02.034","article-title":"Susceptibility to virus\u2013cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains","volume":"376","author":"Malinowsky","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0115","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2006.02.007","article-title":"Virus entry: Open sesame","volume":"124","author":"Marsh","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0120","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1146\/annurev-biochem-060208-104626","article-title":"Virus entry by endocytosis","volume":"79","author":"Mercer","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1615\/CritRevImmunol.v31.i6.20","article-title":"Induction and function of IFNbeta during viral and bacterial infection","volume":"31","author":"Nagarajan","year":"2011","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0130","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1128\/JVI.01917-06","article-title":"Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits","volume":"81","author":"Naito","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0135","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1172\/JCI80713","article-title":"Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma","volume":"125","author":"Nakashima","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0140","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1128\/JVI.79.2.1191-1206.2005","article-title":"Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus","volume":"79","author":"Naranatt","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0145","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/MCB.26.8.3106-3113.2006","article-title":"Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation","volume":"26","author":"Nusinzon","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0150","doi-asserted-by":"crossref","first-page":"22816","DOI":"10.1074\/jbc.M703019200","article-title":"Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch","volume":"282","author":"Panne","year":"2007","journal-title":"Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.cr.7290309","article-title":"The host type I interferon response to viral and bacterial infections","volume":"15","author":"Perry","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0955-0674(00)00180-0","article-title":"Viral transport and the cytoskeleton","volume":"13","author":"Ploubidou","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0165","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.cub.2006.09.014","article-title":"Microtubule acetylation promotes kinesin-1 binding and transport","volume":"16","author":"Reed","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0170","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.chom.2013.10.012","article-title":"HIV-1 induces the formation of stable microtubules to enhance early infection","volume":"14","author":"Sabo","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0175","first-page":"167","article-title":"TLR-mediated activation of type I IFN during antiviral immune responses: Fighting the battle to win the war","volume":"316","author":"Severa","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0180","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1128\/JVI.01911-09","article-title":"Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif","volume":"84","author":"Shao","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0185","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/JVI.02665-13","article-title":"Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation","volume":"88","author":"Shin","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-012-8293-7","article-title":"Activation and regulation of interferon-beta in immune responses","volume":"53","author":"Sin","year":"2012","journal-title":"Immunol Res"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.1094823","article-title":"How viruses enter animal cells","volume":"304","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0200","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0966-842X(00)01824-2","article-title":"Mechanisms of viral transport in the cytoplasm","volume":"8","author":"Sodeik","year":"2000","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0205","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability","volume":"12","author":"Stopak","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00709-010-0152-6","article-title":"Mechanisms of viral entry: Sneaking in the front door","volume":"244","author":"Thorley","year":"2010","journal-title":"Protoplasma"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0220","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1091\/mbc.E05-04-0354","article-title":"Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection","volume":"16","author":"Valenzuela-Fernandez","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12977-015-0181-5","article-title":"The HDAC6\/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation","volume":"12","author":"Valera","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0230","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13238-014-0120-6","article-title":"Overexpression of Hdac6 enhances resistance to virus infection in embryonic stem cells and in mice","volume":"6","author":"Wang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0235","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.virol.2010.12.024","article-title":"The taking of the cytoskeleton one two three: How viruses utilize the cytoskeleton during egress","volume":"411","author":"Ward","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0240","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1242\/jcs.119685","article-title":"Virus entry at a glance","volume":"126","author":"Yamauchi","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0245","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni.1876","article-title":"The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway","volume":"11","author":"Yang","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/107999002753452674","article-title":"Control of IRF-3 activation by phosphorylation","volume":"22","author":"Yoneyama","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","article-title":"HDAC6 modulates cell motility by altering the acetylation level of cortactin","volume":"27","author":"Zhang","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2016.04.005_bb0260","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1038\/emboj.2011.351","article-title":"PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and beta-catenin","volume":"30","author":"Zhu","year":"2011","journal-title":"EMBO J"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T16:25:01Z","timestamp":1536769501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816300468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":52,"alternative-id":["S0163725816300468"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.04.005","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diverse roles of HDAC6 in viral infection: Implications for antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}